Published in Obesity and Diabetes Week, May 8th, 2006
Study 1: Type 2 diabetes mellitus patients receiving higher sulfonylurea drug exposure experience increased mortality.
According to recent research published in the Canadian Medical Association Journal, "Over the past 30 years, the relation between use of sulfonylureas to treat type 2 diabetes and the risk of cardiovascular events has been vigorously debated. The purpose of this study was to determine if the risk of death changes with level of exposure to sulfonylurea drugs. This was a retrospective, inception cohort study using administrative data from...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.